Kurisu Ken, Sato Kaoruko, Matsuoka Mikiko, Otani Makoto, Yoshiuchi Kazuhiro
Department of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Biopsychosoc Med. 2023 Mar 8;17(1):9. doi: 10.1186/s13030-023-00269-2.
We previously reported a case that led us to hypothesize that decreased production of thrombopoietin (TPO) leads to thrombocytopenia in patients with anorexia nervosa (AN) with severe liver dysfunction and that prolonged prothrombin time-international normalized ratio (PT-INR) predicts thrombocytopenia in such cases. To validate this hypothesis, we report another case in which TPO levels were measured. In addition, we examined the association between prolonged PT-INR and thrombocytopenia in such patients.
Similar to the previously reported patient, a patient with AN with severe liver dysfunction showed that TPO levels increased after improvements in liver enzyme levels and PT-INR, followed by recovery of platelet count. In addition, a retrospective study was also conducted to review patients with AN whose liver enzyme levels were > 3 × the upper limit of normal (aspartate aminotransferase > 120 U/L or alanine aminotransferase > 135 U/L). The study included 58 patients and showed a correlation coefficient of -0.486 (95% confidence interval [CI], -0.661 to -0.260; P < 0.001) between maximum PT-INR and minimum platelet count. These patients showed higher PT-INR (β, 0.07; 95% CI, 0.02 to 0.13; P = 0.005) and lower platelet count (β, -5.49; 95% CI, -7.47 to -3.52; P < 0.001) than the 58 matched control patients without severe liver dysfunction, even after adjusting for body mass index.
In patients with AN with severe liver dysfunction, prolongation of PT-INR could predict thrombocytopenia, which may be mediated by decreased TPO production due to decreased hepatic synthetic function.
我们之前报道过一个病例,由此我们推测,在患有严重肝功能不全的神经性厌食症(AN)患者中,血小板生成素(TPO)生成减少会导致血小板减少,并且在这类病例中,凝血酶原时间-国际标准化比值(PT-INR)延长可预测血小板减少。为验证这一假设,我们报告另一例检测了TPO水平的病例。此外,我们研究了这类患者PT-INR延长与血小板减少之间的关联。
与之前报道的患者相似,一名患有严重肝功能不全的AN患者显示,肝酶水平和PT-INR改善后TPO水平升高,随后血小板计数恢复。此外,还进行了一项回顾性研究,以评估肝酶水平>正常上限3倍(天冬氨酸转氨酶>120 U/L或丙氨酸转氨酶>135 U/L)的AN患者。该研究纳入了58例患者,结果显示最大PT-INR与最低血小板计数之间的相关系数为-0.486(95%置信区间[CI],-0.661至-0.260;P<0.001)。即使在调整体重指数后,这些患者的PT-INR(β,0.07;95%CI,0.02至0.13;P=0.005)高于58例无严重肝功能不全的匹配对照患者,血小板计数(β,-5.49;95%CI,-7.47至-3.52;P<0.001)低于后者。
在患有严重肝功能不全的AN患者中,PT-INR延长可预测血小板减少,这可能是由于肝脏合成功能下降导致TPO生成减少所介导的。